Key result
Microalbuminuria in asymptomatic type 2 diabetes patients was associated with a higher frequency of stress-induced ischemia compared to those without (87.5% vs 39.3%; OR 10.81, 95% CI 4.33-26.99).
Why the study?
Diabetic patients face an increased risk of cardiovascular events and poor CAD prognosis, highlighting the need to evaluate microalbuminuria as a predictor of silent myocardial ischemia using myocardial perfusion imaging.
Does the presence of microalbuminuria predict silent myocardial ischemia in asymptomatic patients with type 2 diabetes?
Cross-Sectional (n=120)
Does the presence of microalbuminuria predict silent myocardial ischemia in asymptomatic patients with type 2 diabetes?
Odds Ratio: 10.81 (95% CI 4.33–26.99)
Absolute Event Rate: 87.5% vs 39.3%
p-value: p=<0.001
Microalbuminuria is strongly associated with silent myocardial ischemia in asymptomatic patients with type 2 diabetes, suggesting it could serve as a useful biomarker for screening.
Microalbuminuria may flag silent ischemia risk in type 2 diabetes; leaves open whether it should guide MPI screening.
Objectives: In light of increased risk of cardiovascular events and the poor prognosis of coronary artery disease (CAD) in diabetic versus non-diabetic patients and also with respect to the importance of early diagnosis of CAD in this status, the study was aimed to assess the importance of microalbuminuria in predicting silent myocardial ischemia (SMI) in patients with type 2 diabetes using myocardial perfusion imaging (MPI). Methods: This study included 120 patients with diabetes type 2, but without previously known CAD or any cardiac symptoms that were stratified into two groups based on presence/absence of microalbuminuria. All participants underwent CAD evaluation using gated myocardial perfusion single-photon emission computed tomography (MPS) imaging. Other clinical and laboratory indices were also recorded Results: Studied population consisted of 84 males (70%) and 36 females (30%), totally 120 patients with mean age of 58.61±9.90). In total, asymptomatic ischemia was detected in 78 (65%) of the included diabetic patients. Stress induced ischemia was found in 56 patients (87.5%) of albumin+ (Alb) group and in 22 patients (39.3%) of Alb- group. The frequency of stress induced ischemia was 10.81 times higher in the patients with microalbuminuria compared to Alb- ones [p<0.001, Odds ratio: 10.81, 95% confidence interval: 4.33-26.99]. On the other hand, no relationship was found between the presence of stress induced ischemia and therapy type, diabetes duration, history of evident retinopathy, history of hypertension and also serum levels of hemoglobin A1c (p>0.05). Conclusion: The current study showed that abnormal MPI findings are significantly more common in diabetic patients with microalbuminuria. With respect to low cost and availability of urine Alb detection tests, it might be as a biomarker for prediction of SMI in daibetic population.
No takes yet. Share an insight, caveat, or question.
Emami et al. (2019) conducted a cross-sectional in Type 2 diabetes without known coronary artery disease (n=120). Microalbuminuria vs. Absence of microalbuminuria was evaluated on Stress induced ischemia (OR 10.81, 95% CI 4.33-26.99, p=<0.001). Microalbuminuria in asymptomatic type 2 diabetes patients was associated with a higher frequency of stress-induced ischemia compared to those without (87.5% vs 39.3%; OR 10.81, 95% CI 4.33-26.99).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: